chrisvoncsefalvay/vaers-outcomes huggingface dataset:
cough; congestion; runny nose; sore throat; swollen lymph nodes; chills; fatigue; fever; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 19Apr2021 at 15:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), fluoxetine hydrochloride (PROZAC) and multivitamin (MANUFACTURER UNKNOWN) all for unknown indications on unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left  arm on 29Mar2021 at 15:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021, on day 1, the patient experienced chills, fatigue and fever. On day 2, the patient still had fatigue. On 21Apr2021, on day 3, the patient experienced cough, congestion, runny nose, sore throat, swollen lymph nodes, fatigue. Days 5-7, the patient continued to have congestion and runny nose. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures for the reported events included treatment with albuterol and TESSALON PERLES. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fatigue, fever, cough, congestion, runny nose, sore throat and swollen lymph nodes were resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
the patient states that she felt a "pop" when the shot was given high in the upper arm.  Her arm hurts when she lifts her arm or rotates her arm. She wakes up at night with arm pain.
I have minimal information but wanted to report as patient's wife is unsure if patient's death is related to his vaccine. Patients wife, called me and was very hard to understand but was able to tell me that her seemingly healthy 42 year old husband died out of nowhere on Wednesday August 18th, 13 days after receiving his second dose of the Pfizer vaccine. They are not sure what the patient died from, the wife states everything happened so fast and she said she wasn't sure if he was having a seizure or a heart attack. According to the wife an autopsy is being performed to discover cause of death. Patient had no complaints after his first dose, and only had normal possible side effects after his first dose.
Pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 38-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Ehlers-Danlos syndrome, Anxiety since 2003, Depression since 2003 and Herpes NOS. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]), VALACYCLOVIR [VALACICLOVIR] and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 05-Jan-2021 and the estimated date of delivery was 12-Oct-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Pregnancy test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.
Abnormal swelling and erythema. Erythema measuring 16cm with a 4cm area of induration located around MENACTRA site. Erythematous area is hot to the touch. Patient c/o pruritus and tenderness to palpation.
face has bumps; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SKIN MASS (face has bumps) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN MASS (face has bumps). At the time of the report, SKIN MASS (face has bumps) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. The treatment information was unknown.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Non-significant follow up appended
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 09-DEC-2015, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 09-DEC-2015, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Complained of nausea, was diaphoretic within a few minutes of receiving the vaccine.  BP 80/50, pulse-66.  Relief with rest, after 10 minutes BP 98/70, pulse-72.
temp of 102, sore throat, cough w/greenish mucuous, body aches;
Initial report was received from a lay press report on 16 November 2011. Verbatim from report: "Ordinary flu vaccine has always worked out for a 77-year-old was perplexed on a recent Monday when her clinic gave her a high-dose version without asking first. Confusion turned to anger that night as she lay in bed at her home. Her muscles ached, her head pounded and her stomach churned. "I've had the flu shot before and never had a problem", she said. "Why was this different?" She was back to full strength the following Friday. But she wonders if she would have taken the high-dose version if her clinic had offered her a choice. The outcome was not reported. Documents held by sender: none.
sore arm; arm is red; back pain; carpel tunnel pain; a pain from his wrist all the way to his forearm; blurry vision; little swollen arm; joint soreness; headache; This spontaneous case was reported by a consumer and describes the occurrence of   in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ROSUVASTATIN, FINASTERIDE and AZILSARTAN MEDOXOMIL, CHLORTALIDONE (EDARBYCLOR) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
pt recvd vax 10MAR94 & devel fever of 102 next day; went to hosp 3 days later for fever, fussiness dry heaves; t38 RSC cx x-ray; diarrhea, trouble breathing, also OM, lethargy;
"A reaction that almost appeared to be vagal like. He became light headed, got pale and felt like he was going to throw up." Pulse 88.
SATURDAY(DAY OF VACINNE): 10-15 MINTUES AFTER VACCINATED,  I HAD A MEDCINE TASTE IN MY MOUTH, THE TIP OF MY TONGUE FELT NUMB, THE UPPPER LIP AND LOWER LIP CLOSED TO THE TIP OF MY TONGUE ALSO FELT NUMBED; MY HEART FELT IT WAS RACING VERY FAST. I QUICKY DRANK A  BOTTLE OF WATER TO FLUSH MY SYSTEM,  I ALSO FELT LIKE I WANT TO THROW UP.  THE NUMBNESS OF MY TONGUE AND LIPS WENT AWAY,; ABOUT 3HRS OR SO  LATER  I FELT THAT I  WAS EXTREMELY THRISTY, MY MOUTH FELT VER DRY. LATE AT NIGHT I STARTED  HAVING DIARRHEA   SUNDAY: MY WHOLE BODY ACHES, ESPECIALLY THE JOINTS, SEVERED HEADACHES WITH HOT AND COLD CHILL; DIARRHEA CONTINUED ; EXTREMELY TIRED  MONDAY: STILL HAVE PAIN IN JOINTS, WITH SWEAT(FEEL VERY HOT) WITH SEVER HEADACHES, EXTREMELY TIRED.  TUESDAY:  BODY ACHES/HEADACHES CONTINUE. I TOOK IBUPROFEN AND THAT SEEMS TO HELP
Fever, chills, swelling and redness at site of shot, also very hot to the touch.
This spontaneous report as received from a registered nurse refers to a 5 year old female patient. The nurse reports that she received a voice mail from a patient's mother. The patient had no known drug allergies or reactions, there was no patient medical history. On 21-JUL-2015, the patient was vaccinated with a dose of PROQUAD (dose was not reported) lot # K009890, expiration date 11-JAN-2016, subcutaneous. Secondary suspects and concomitant therapies were not reported. Approximately in July 2015, the patient experienced fever (unspecified temperature). There was no lab diagnostics studies performed. The outcome of fever was reported as not recovered. The relatedness between fever and PROQUAD (Merck) was not reported. Additional information has been requested.
Full body aches, nausea, loss of appetite, cold sweats, fever of 100.8, fatigue.
8 hours after arm soreness began, lasted 3/4 days, then redness began and spread larger shoulder/elbow, hot/red/itchy, 2/2/21 pt had to see PCP and was diagnosed with Cellulites-Benadryl once daily , Antibiotic-Ciprofloxacin 500 mg twice daily for 10 days
Pt presented with a red painful rash at the injection site. It is about 2 inches in diameter. She developed rash one day after injection and came to pharmacy 12/28/11. Pt says it does itch a little.
Hep A #2 dose was given early and is considered invalid.  No adverse side effects reported
Initial arm pain for 3 days, along with fatigue for 4 days, headache for 7 days. At 8 days, noticed a red, warm, and tender oblong shaped spot around the injection site, which has remained for last two days. Pain is different than initial muscle soreness from injection and feels more superficial to the skin. Reported to occupational health nurse and am monitoring for increased size, warmth, pain, or streaking.
This spontaneous report was received from a pharmacist referring to two patients of unknown age (demographics not provided). The patient's concurrent conditions and medical histories were not reported. On 20-OCT-2015, the patients were vaccinated with ZOSTAVAX (lot # L028279, expiration date on 28-OCT-2016) (dose, frequency, route and concentration were not provided). On 21-OCT-2015, the patients experienced injection site reaction. The outcome of injection site reaction was unknown. The primary reporter did not provide the causality between ZOSTAVAX and injection site reaction. This is one of several reports received from the same source. Additional information has been requested.
Received notice on my cell that I had been exposed to someone with a positive test while on a cruise vacation (May 14/15) 4 to 5 days after the fact. At that time, I had experienced a runny nose and some body aches prior to being notified. I contacted the Clinic to schedule a Covid test. I tested positive on May 20th. Dr. advised me to schedule a virtual visit to discuss Paxlovid therapy due to my pre-existing conditions. I spoke with PA-C at the Clinic and she prescribed the Paxlovid therapy for me.   My brother picked up the RX for me and I started that day. I had 2 therapies that day as well as for the following 4 days afterwards. May 21 to May 25.   My symptoms remained minor with a sore throat, phlegm producing throat, and cough. Some minor body aches as well, but no major symptoms besides those. I did have a horse voice for a number of days as well.  I never had any fever, my taste and smell were not effected, and it did not go into my chest, so my breathing did not seem to be effected.
pt recv vax 21MAY98 & fever 101-102;22MAY98 malaise, inj fifty cent size red w/knot, warm to touch;rash around inj site;
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were subcutaneously vaccinated with improperly stored doses of VARIVAX (dose was not reported, lot # L011085 with expiry date of 01-APR-2017, lot# L012036 with expiry date of 07-APR-2017 and lot # reported as M012990 with expiry date of 14-MAR-2018). No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On an unknown date in 2007, the patient was vaccinated with ZOSTAVAX as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, anatomical location, lot#, expiration date were unknown). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles (onset date was not provided). On an unknown date in 2015, the patient was treated by the physician for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. The reporter determined the events to be related to the ZOSTAVAX.
Blood in stool at 2am after the vaccination. He continued to have bloody stools. Was taking to urgent care. He had fever of 102.2. He continued to have bloody diapers and was sent to the main hospital. He was dehydrated and was diagnosed with rotavirus and salmonella. He was perfectly healthy and fine before the immunizations.
Noticed headache an hour after receiving dose; injection site red and swollen following morning, felt itching to area later in the day then fever; day 2 now with some intermittent burning and slight fever; found out later that dose #1 in series received at age 5 caused some reaction as well.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history or concurrent condition was not provided. On 17-JUN-2015, the patient received a dose of improperly stored MMR II 0.5 ml, (lot # J014876, expiration date 21-NOV-2015, therapy type rHA (recombinant human albumin)) subcutaneously. Concomitant drug was not reported. No adverse effects were reported. It was unknown whether the patients sought medical attention. This is one of several reports received from the same reporter. Additional information has been requested.
Left arm (injection site) became swollen and hard about 6 days after receiving the vaccine.   There is a large hard lump and my arm is very sore, itchy and warm.  I have been extremely tired all week.
Left upper thigh area reddened. No warmth or tenderness or swelling. Warm compresses applied.
This spontaneous report as received from a medical assistant refers to a 24 year old female patient with no drug allergies or medical history reported. On 20-NOV-2012 the patient was vaccinated with the first dose of GARDASIL (lot#0459AE, Exp. 13-DEC-2014) intramuscularly in the left deltoid. Concomitant medication included: unspecified "oral birth control". On 22-JAN-2013 the patient was vaccinated with the second dose of GARDASIL (lot # H017698, Exp. 02-JUL-2015) intramuscularly in the left deltoid. The patient called the physician's office the next day stating that "she went to the emergency room on the evening of 22-JAN-2013 because she felt like her throat was swelling up". The emergency room was unspecified. No lab diagnostics studies was performed. The patient stated that the unspecified emergency room physician said "the reaction was mild, not severe, and sent her home with BENADRYL". The outcome of felt like her throat was swelling up was reported as recovered/resolved on an unknown date. Additional information has been requested.
Pt recvd vax 22JUN92 & c/o pain in the arm; approx 3' later, pt slumped backwards to the wall from a sitting position; eyes rolled back, pupils were dilated, twitching x 3 sec; dizzy;
Rt deltoid w/redness, itching & swelling x 1 wk p/inject;
INCORRECT ROUTE OF DRUG ADMINISTRATION (VACCINE WAS GIVEN SUBCUTANEOUS AND NOT INTRAMUSCULAR); OFF LABEL USE; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, subcutaneous, batch number: Unknown) dose was not reported, administered on 08-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 08-OCT-2021, the patient experienced incorrect route of drug administration (vaccine was given subcutaneous and not intramuscular). On 08-OCT-2021, the patient experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the incorrect route of drug administration (vaccine was given subcutaneous and not intramuscular) and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211018346.
Bell's Palsy, rx prednisone 25mg twice daily, acyclovir 400mg 5 times daily, local care to eye
sore arm at injection site; burning at arm pit; Vaginal itching; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A female patient received bnt162b2 (COMIRNATY), administration date Oct2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "sore arm at injection site"; BURNING SENSATION (non-serious) with onset 2021, outcome "recovered", described as "burning at arm pit"; VULVOVAGINAL PRURITUS (non-serious) with onset 2021, outcome "unknown", described as "Vaginal itching".  Additional Information: Patient got the first dose two weeks ago yesterday.  Follow-up attempts are completed. No further information is expected. The lot/batch number is not available despite the follow-up attempts made.
Patient complained of fast heart beat after TD vaccine. Duration according to the patient was from 8pm on 1-4-10 to 8 am 1-5-10.
Benadryl q 4 hr x 48 hr. Swelling, redness, painful to Rt bicep measurements 5" long 3" wide 7" circ. Reaction to PPV23.
SkinRash, Rash, hives across sholders and waist and down arm, hx ITP and antiphylaxis Narrative: took po benadryl, her physician advised her not to take second dose
Dizziness; Tiredness; headaches; Fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), FATIGUE (Tiredness), HEADACHE (headaches) and PYREXIA (Fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002a21a) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included SALBUTAMOL (VENTOLINE [SALBUTAMOL]) and FORMOTEROL FUMARATE, MOMETASONE FUROATE (DULERA) for Asthma.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced DIZZINESS (Dizziness), FATIGUE (Tiredness), HEADACHE (headaches) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 650 milligram. At the time of the report, DIZZINESS (Dizziness), FATIGUE (Tiredness), HEADACHE (headaches) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Father of baby said baby suddenly went limp and unresponsive, was transported to hospital via ambulance CPR in progress.
Severe fever, chills, body ache and headache until Tuesday 11/9 at 2pm. From that point on lingering severe headache
On 01/04/2023 I received my Covid-19 vaccine. Around 01/27/2023 my throat started feeling raw. Then around the 29th of January symptoms gotten worse and I tested positive for Covid-19. I reached out to my doctor and was prescribed PAXLOVID. Symptoms are still ongoing.
Information has been received from a certified medical assistant (CMA) concerning a 17 year old female who was vaccinated with a second dose of Gardasil five week after vaccination with the first dose. Subsequently, the patient developed a "bruise" at the injection site. The patient sought unspecified medical attention. The outcome of the patient's injection site bruising was unknown. Additional information has been requested.
4/23/2021 felt rundown & tired. 4/24/2021 flu like symptoms, sore throat, high bp 152/98 . So far no fever if my thermometer is accurate. 97.8.
It was reported that a 33-year-old female received the TD vaccine on 8/24/99. At some point following the vaccination the patient experienced redness, swelling, and a hardness surrounding the injection site. From follow-up received on 5/15/01, it was reported, "No further information available regarding this patient or this case." This case is closed.